AccuGel 29:1 is safe for 24 months when saved tightly capped in a darkish area at room temperature. Potential Effectively being OutcomesInhalation
Inhalation of mist causes irritation to the respiratory tract. Indicators may parallel ingestion. Ingestion
Toxic! May set off systemic poisoning. May set off drowsiness, tingling sensations, fatigue, weak spot, stumbling, slurred speech, and shaking. May set off central and peripheral nervous system harm. Excessive intoxication may set off eternal nerve harm. May affect reproductive system and act as a teratogen.
Reliable
AccuGel 29:1 is a stabilized, ready-to-use decision of 40% (w/v) acrylamide : bisacrylamide(29:1). AccuGel 29:1 has zero acrylic acid content material materials, eliminating the fixed costs that set off band streaking. Furthermore, oxidation merchandise similar to aldehydes have been eradicated by a selective adsorption course of. With AccuGel 29:1, you presumably can perception that your outcomes may be fixed from one electrophoretic run to the next.
Improved Safety
AccuGel 29:1 reduces publicity to neurotoxic acrylamide mud by eliminating the need for coping with and weighing sturdy acrylamide and methylene bisacrylamide, which often ends in airborne particulate that could be readily inhaled. In your security, AccuGel 29:1 is provided in PVC coated shatter-proof bottles.
Accu Gels
Pores and pores and skin
May set off irritation and redness. May very well be absorbed by the use of the pores and pores and skin inflicting systemic poisoning; indicators may parallel ingestion. Eyes
Acrylamide choices may set off eye irritation. Carcinogenicity
Acrylamide is suspected as a most cancers hazard. May set off most cancers. Listed by NTP as a suspected carcinogen. Acrylamide is known to the State of California to set off most cancers. Mutagenicity
Acrylamide was unfavourable throughout the Ames assay every with and with out metabolic activation. Reproductive Toxicity
Acrylamide induced male reproductive toxicity has been demonstrated in Prolonged-Evans rats the place given greater than or equal to 15 mg/kg/day acrylamide orally by gavage for five consecutive days. On this analysis, males receiving greater than or equal to 15 mg/kg/day acrylamide had a decreased fertility index.
